newsfilter
← Latest News
PR Newswire·

Poseida Therapeutics Provides Financial Results for the Second Quarter of 2023

SAN DIEGO, Aug. 8, 2023 /PRNewswire/ -- Poseida Therapeutics, Inc. (NASDAQ:PSTX), a clinical-stage cell and gene therapy company advancing a new class of treatments for patients with cancer and rare diseases, today